Concept

Key Discussion and Conclusion Points from the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study

  • There is some research to support CQ's (and HCQ its derivative) use as an antiviral treatment for viruses that involve severe immune responses
  • CQ has been shown in one study to stop SARS-CoV-2 from replicating in vitro
  • There is data to suggest that HCQ can counteract the cytokine storm that can occur with COVID-19
  • More studies need to be conducted to more concretely determine HCQ's efficacy in fighting COVID-19 for the wider population

0

1

Updated 2020-08-10

Contributors are:

Who are from:

Tags

SARS-CoV-2 (COVID-19)

Biomedical Sciences